Private equity firm Ardian, until recently known as AXA Private Equity, has entered exclusive negotiations to acquire a majority stake in hospital disinfection specialist Laboratoires Anios from Air Liquide.
Ardian said it was eager to support with Laboratoires Anios CEO Bertrand Letartre and deputy CEO Thierry Letartre in their growth strategy for the business.
The proposed transaction remains subject to the signing of a definitive agreement and approvals by the French antitrust authorities and the works council bodies of Laboratoires Anios, the firm said.
Based in the outskirts of Lille, France, Laboratoires Anios was founded by Fernand Collet-Delaval in 1898 and is now managed by his descendants, Bertrand and Thierry Letartre As well as its primary focus on the healthcare sector, Laboratoires Anios also operate in the food-processing, cosmetics, and pharmaceutics industries, as well as working with businesses involved in accommodation and catering.
Laboratoires Anios employs around 450 people worldwide, of which 350 are based in France. The company’s two main production sites are located in Sainghin-en-Mélantois and in Hellemmes, France. In 2012 it recorded a turnover of €178m, increasing organic growth by seven per cent on the previous year.
Ardian said it will look to support Laboratoires Anios accelerate its international footprint, with 30 per cent of its turnover already being generated outside France. International build up acquisitions will form the heart of the company’s growth strategy, which will be supported by ongoing investment, notably in R&D.
Philippe Poletti, head of mid market enterprise capital at Ardian, said, “This transaction fits perfectly with Ardian’s investment strategy. Laboratoires Anios have all the key indicators of future success – they are a leader in a growing niche market, and has real potential for considerable international growth. We will provide Laboratoires Anios with all necessary resources to support the company’s ambitious development plans.”
Copyright © 2013 AltAssets